Position in CBLL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,713,205
+$1,448,721 QoQ
Shares Held
345,152
+20.2% QoQ
Ownership
0.899%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 123 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,252,029,704 across 101 Medical Devices names. CBLL ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in CBLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,713,205 | 345,152 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,264,484 | 287,206 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,509,255 | 388,019 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,724,456 | 411,180 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $7,117,455 | 380,003 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $111,878 | 5,824 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $880,256 | 34,013 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||